|Sarsia Seed Management AS||Partner||Norway|
How are collaborations key to improve innovation in metabolic diseases?
Dr. Abdi-Dezfuli’s background is in preclinical and clinical research with drug development experience from Eli Lilly and Company culminating as Team Leader Medical Lilly Norway. Since 2006, he has been engaged as a Partner at Sarsia Seed Management AS (www.sarsiaseed.com) which administers the Sarsia Seed Fund, the only dedicated life science seed fund in Norway. Dr. Abdi-Dezfuli received his doctorate in pharmacology/Endocrinology from the Univeristy of Edinburgh Medical School and his postdoctoral training from Haukeland University Hospital Bergen, Norway.